Subscribe to RSS - Invacare


Invacare settles shareholder lawsuit

‘This has been a significant distraction’

ELYRIA, Ohio – Invacare has reached a settlement with two shareholders that claim the company’s board of directors and management team “breached their fiduciary duties” in connection with its compliance with U.S. Food and Drug Administration (FDA) regulations.

In brief: Stakeholders organize, OIG investigates


WASHINGTON – Industry stakeholders last week submitted comments to CMS outlining concerns with a recent wave of claims against surety bonds—some triggered by overpayments as low as $16. The stakeholder, which include the Wayne van Halem Group, U.S.

In brief: Bill to repeal device tax gains ground, OMB seeks comments on PMD demo


WASHINGTON – A bill to repeal a 2.3% tax on medical devices cleared the Ways and Means Committee in the House of Representatives last week, but industry stakeholders aren’t getting their hopes up.

Invacare: 'The future is good'


During Invacare’s earnings call in April, President and CEO Gerald Blouch also addressed:


In brief: FBI agents raid HME offices, CRE releases bidding analysis


In brief: FBI agents raid HME offices, CRE releases bidding analysis

Invacare briefs shareholders on FDA, earnings

Also: ResMed reports double-digit growth

ELYRIA, Ohio – Invacare expects to engage a third-party to audit its compliance with U.S. Food and Drug Administration (FDA) regulations in the fourth quarter of this year, company officials said during a conference call this week to discuss first quarter earnings.

Invacare, Invamex and the FDA

Tuesday, January 31, 2012

I spoke briefly with Kelly Mize and Brian Ellacott of Invacare yesterday about the company's decision to move the manufacturing of its Solara line of manual wheelchairs to an existing facility in Reynosa, Mexico.

FDA negotiations and law firm investigations

Wednesday, December 28, 2011

Did anyone else notice the flurry of law firms that announced they're investigating Invacare's board of directors following the company's Dec.